Cough News and Research RSS Feed - Cough News and Research

Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Neos Therapeutics, Inc., a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product candidates for the treatment of attention-deficit/hyperactivity disorder (ADHD), today announced that Adzenys XR-ODT™ is in distribution channels and is now available to prescribe for patients with ADHD in the United States. [More]
Tdap vaccine safe for mothers and infants

Tdap vaccine safe for mothers and infants

Tetanus-diphtheria-acellular pertussis (Tdap) vaccine is recommended for all pregnant women in the U.S. as the key medical intervention to protect newborn infants from pertussis (whooping cough). [More]
New national survey reveals that asthma patients most frequently use rescue inhaler

New national survey reveals that asthma patients most frequently use rescue inhaler

In a new national survey of asthma patients, Health Union, and its new online community Asthma.net, reveals that most were satisfied with the care they received; however, the most frequently used form of treatment, at 89%, is the rescue inhaler. [More]
New survey shows many adults unaware of common asthma symptoms

New survey shows many adults unaware of common asthma symptoms

A new national asthma survey commissioned by National Jewish Health shows that many adults are unaware of common symptoms of asthma in adults. Doctors say that the findings explain why many adults with asthma may not realize that they have the disease, and don't seek treatment that can help them. [More]
New set of practice guidelines from WMS may help in treatment, prevention of drowning

New set of practice guidelines from WMS may help in treatment, prevention of drowning

Drowning is a global threat to human health. Each year, more than 372,000 people die as a result of drowning, with many of those deaths being preventable by simple water safety measures. In order to arm professionals with the most up-to-date clinical protocols, the Wilderness Medical Society has issued a new set of practice guidelines for both the treatment and prevention of drowning, published in the society's official journal, Wilderness and Environmental Medicine. [More]
Janssen gets positive CHMP opinion for IMBRUVICA (ibrutinib) to treat patients with previously untreated CLL

Janssen gets positive CHMP opinion for IMBRUVICA (ibrutinib) to treat patients with previously untreated CLL

Janssen-Cilag International NV today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a Positive Opinion, recommending broadening the existing marketing authorisation for ibrutinib as a single agent for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL). [More]
TGen scientists trace likely origins, dispersal of fungus that causes Valley Fever

TGen scientists trace likely origins, dispersal of fungus that causes Valley Fever

Using the latest in genomic analysis technologies, scientists at the Translational Genomics Research Institute have tracked the likely origins and dispersal of the fungus that causes Valley Fever, according to a study published today in the journal mBio, the premiere journal for reporting high impact microbiological research. [More]
Criminology theory to combat counterfeit, sub-standard medicines

Criminology theory to combat counterfeit, sub-standard medicines

Around the world, especially in developing nations, counterfeit medicines are a real problem. Until now, in many countries there hasn't been a standard protocol to conduct investigations and pursue prosecution. [More]
Pediatric researchers develop minimally invasive techniques to treat plastic bronchitis

Pediatric researchers develop minimally invasive techniques to treat plastic bronchitis

Pediatric researchers have devised an innovative, safe and minimally invasive procedure that helps relieve rare but potentially life-threatening airway blockages occurring in children who had surgery for congenital heart defects. [More]
NObreath®: the essential tool for World Asthma Day

NObreath®: the essential tool for World Asthma Day

This year, apprehensions have been rising about asthma after recent studies uncovered some horrific truths about asthma; Asthma UK found that over 120,000 asthma sufferers in the UK are at risk from wrongly prescribed medication, whilst NICE published their findings that 30% of people with asthma are suspected to have been misdiagnosed. [More]
New KidsMD Alexa skill device allows parents to get easier to access medical information

New KidsMD Alexa skill device allows parents to get easier to access medical information

"My child has a fever of 101. Should I be concerned?" Through a new skill created for Amazon Alexa-enabled devices, parents will now be able to ask Alexa a variety of questions around fever and other common symptoms. The KidsMD Alexa skill was developed by the Innovation & Digital Health Accelerator team at Boston Children's Hospital and launched today. [More]
Study finds link between low pollution levels and stronger lungs in California kids

Study finds link between low pollution levels and stronger lungs in California kids

A USC study that tracked Southern California children over a 20-year period has found they now have significantly fewer respiratory symptoms as a result of improved air quality. [More]
Air pollution reduction linked to decrease in bronchitic symptoms in children

Air pollution reduction linked to decrease in bronchitic symptoms in children

Decreases in ambient air pollution levels over the past 20 years in Southern California were associated with significant reductions in bronchitic symptoms in children with and without asthma, according to a study appearing in the April 12 issue of JAMA. [More]
Lung ultrasound may be highly effective, safe for diagnosing pneumonia in children

Lung ultrasound may be highly effective, safe for diagnosing pneumonia in children

Lung ultrasound has been shown to be highly effective and safe for diagnosing pneumonia in children and a potential substitute for chest X-ray, according to a study conducted at the Icahn School of Medicine at Mount Sinai. Results are currently published in the medical journal Chest. [More]
USPSTF does not recommend screening for COPD

USPSTF does not recommend screening for COPD

The U.S. Preventive Services Task Force does not recommend screening for chronic obstructive pulmonary disease (COPD) in persons who do not have symptoms suggestive of COPD. The report appears in the April 5 issue of JAMA. [More]
Understanding idiopathic pulmonary fibrosis: an interview with Michael Durheim, M.D.

Understanding idiopathic pulmonary fibrosis: an interview with Michael Durheim, M.D.

IPF is a rare and fatal lung disease that causes permanent scarring of the lungs, leading to debilitating shortness of breath and cough in affected patients. It affects as many as 132,000 Americans, most commonly those over the age of 65. [More]
Investigators predict that new pneumonia epidemic in Beijing will likely to continue for longer time

Investigators predict that new pneumonia epidemic in Beijing will likely to continue for longer time

Mycoplasma pneumoniae infections began rising in Beijing last spring, and by December, this pathogen was found in more than half of hospitalized children suffering from pneumonia in that city, according to investigators from the Capital Institute of Pediatrics, Beijing, China. [More]
Researchers develop rapid yet inexpensive test for TB

Researchers develop rapid yet inexpensive test for TB

Although tuberculosis (TB) is commonly thought of as being a disease that mainly affects nineteenth century poets and Victor Hugo characters, it is still the second-most common cause of mortality from an infectious disease in the world, killing nearly three people every minute. Every March 24, on World TB Day, the global health community recognizes the work of Robert Koch, who announced on that date in 1882 his discovery of Mycobacterium tuberculosis, the bacteria that causes TB. [More]
IBM's World Community Grid supports TB eradication project

IBM's World Community Grid supports TB eradication project

The University of Nottingham is launching a new study to address tuberculosis (TB), one of the world's most deadly diseases, supported by IBM's World Community Grid -- one of the most powerful and fastest virtual supercomputers on the planet. [More]
Anthim (obiltoxaximab) injection approved for treatment of inhalational anthrax

Anthim (obiltoxaximab) injection approved for treatment of inhalational anthrax

On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate. [More]
Advertisement
Advertisement